MedTrace Logo

Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator

NCT01006993 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2010-03-11

No results posted yet for this study

Summary

To assess the safety and feasibility of using the NeuroFlo catheter to treat acute ischemic stroke patients following administration of intravenous tPA.

Conditions

Interventions

DEVICE

NeuroFlo catheter

NeuroFlo™ catheter 45 minute treatment

Sponsors & Collaborators

  • CoAxia

    lead INDUSTRY

Principal Investigators

  • FASTFlo Steering Committee · Various

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-07-31
Completion
2010-01-31

Countries

  • Canada
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01006993 on ClinicalTrials.gov